SIGA Technologies Inc
SIGA6.700USD
+0.190+2.92%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
479.80MCap. mercado
6.42P/E TTM
Más Datos de SIGA Technologies Inc Compañía
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Información de SIGA Technologies Inc
Símbolo de cotizaciónSIGA
Nombre de la empresaSIGA Technologies Inc
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoNguyen (Diem)
Número de empleados46
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 09
Dirección31 East 62Nd Street
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10065
Teléfono12126729100
Sitio Webhttps://www.siga.com/
Símbolo de cotizaciónSIGA
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoNguyen (Diem)
Ejecutivos de SIGA Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+11847.00%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+21791.00%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
100.75K
+33098.00%
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+13359.00%
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
--
--
Dr. Gary J. Nabel, M.D., Ph.D.
Dr. Gary J. Nabel, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Holly L. Phillips, M.D.
Dr. Holly L. Phillips, M.D.
Independent Director
Independent Director
--
--
Mr. Harold E. Ford, Jr.
Mr. Harold E. Ford, Jr.
Independent Director
Independent Director
--
--
Mr. Lawrence R. (Larry) Miller
Mr. Lawrence R. (Larry) Miller
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+11847.00%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+21791.00%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
100.75K
+33098.00%
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+13359.00%
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.62M
0.00%
Canada
0.00
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
MacAndrews & Forbes Holdings, Inc.
33.73%
Lewis (John Latane IV)
7.36%
BlackRock Institutional Trust Company, N.A.
3.86%
The Vanguard Group, Inc.
3.75%
Dimensional Fund Advisors, L.P.
3.40%
Otro
47.90%
Accionistas
Accionistas
Proporción
MacAndrews & Forbes Holdings, Inc.
33.73%
Lewis (John Latane IV)
7.36%
BlackRock Institutional Trust Company, N.A.
3.86%
The Vanguard Group, Inc.
3.75%
Dimensional Fund Advisors, L.P.
3.40%
Otro
47.90%
Tipos de accionistas
Accionistas
Proporción
Holding Company
33.73%
Investment Advisor/Hedge Fund
21.67%
Investment Advisor
20.61%
Individual Investor
9.62%
Hedge Fund
3.68%
Research Firm
2.08%
Pension Fund
1.56%
Bank and Trust
0.21%
Insurance Company
0.02%
Otro
6.80%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
380
35.62M
49.74%
-3.54M
2025Q3
367
35.40M
49.44%
-5.13M
2025Q2
371
67.74M
94.60%
-3.85M
2025Q1
373
68.25M
95.72%
+20.84M
2024Q4
383
67.66M
94.75%
+19.97M
2024Q3
383
69.27M
97.02%
+23.98M
2024Q2
372
66.53M
93.22%
+21.86M
2024Q1
353
41.88M
58.83%
-3.74M
2023Q4
341
41.95M
58.96%
-4.28M
2023Q3
343
42.34M
59.51%
-1.31M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
MacAndrews & Forbes Holdings, Inc.
24.16M
33.73%
--
--
Apr 17, 2025
Lewis (John Latane IV)
5.27M
7.36%
--
--
Apr 17, 2025
BlackRock Institutional Trust Company, N.A.
2.77M
3.86%
-127.30K
-4.40%
Sep 30, 2025
The Vanguard Group, Inc.
2.62M
3.66%
+142.04K
+5.73%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.43M
3.4%
+24.90K
+1.03%
Sep 30, 2025
AltraVue Capital, LLC.
2.42M
3.38%
-83.63K
-3.34%
Sep 30, 2025
American Century Investment Management, Inc.
1.23M
1.72%
-172.44K
-12.27%
Sep 30, 2025
Citadel Advisors LLC
1.13M
1.57%
-269.33K
-19.31%
Sep 30, 2025
State Street Investment Management (US)
1.03M
1.44%
-76.16K
-6.86%
Sep 30, 2025
Geode Capital Management, L.L.C.
998.22K
1.39%
+274.00
+0.03%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Cambria Micro and SmallCap Shareholder Yield ETF
1.26%
Janus Henderson Small Cap Growth Alpha ETF
0.95%
Acquirers Small and Micro Deep Value ETF
0.89%
Lattice Hartford Multifactor Small Cap ETF
0.56%
Hypatia Women CEO ETF
0.55%
First Trust Dow Jones Select MicroCap Index Fund
0.53%
Invesco NASDAQ Future Gen 200 ETF
0.53%
Royce Quant Small-Cap Quality Value ETF
0.43%
First Trust Active Factor Small Cap ETF
0.41%
ALPS Barron's 400 ETF
0.23%
Ver más
Cambria Micro and SmallCap Shareholder Yield ETF
Proporción1.26%
Janus Henderson Small Cap Growth Alpha ETF
Proporción0.95%
Acquirers Small and Micro Deep Value ETF
Proporción0.89%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.56%
Hypatia Women CEO ETF
Proporción0.55%
First Trust Dow Jones Select MicroCap Index Fund
Proporción0.53%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.53%
Royce Quant Small-Cap Quality Value ETF
Proporción0.43%
First Trust Active Factor Small Cap ETF
Proporción0.41%
ALPS Barron's 400 ETF
Proporción0.23%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
